Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 284,742 $ 293,484
Short-term Deposits 28,300 28,300
Accounts receivable, net 102,212 132,558
Inventories 164,588 168,504
Prepaid expenses 7,056 6,567
Other current assets 19,969 29,659
Total current assets 606,867 659,072
Non-current assets    
Property, plant and equipment, net 194,437 189,706
Goodwill 385,636 385,658
Other intangible assets, net 75,638 87,328
Operating lease right-of-use assets 17,738 20,936
Other non-current assets 33,744 38,819
Total non-current assets 707,193 722,447
Total assets 1,314,060 1,381,519
Current liabilities    
Accounts payable 30,600 35,818
Accrued expenses and other current liabilities 23,743 28,528
Accrued compensation and related benefits 29,548 34,013
Deferred revenues 48,617 52,268
Operating lease liabilities - short-term 8,667 9,292
Total current liabilities 141,175 159,919
Non-current liabilities    
Deferred revenues - long-term 13,489 16,039
Operating lease liabilities - long-term 9,493 12,445
Other non-current liabilities 31,576 35,343
Total non-current liabilities 54,558 63,827
Total liabilities 195,733 223,746
Redeemable non-controlling interests 572 622
Equity    
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands shares; 55,030 thousands shares and 54,441 thousands shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively 150 148
Additional paid-in capital 2,717,963 2,706,894
Accumulated other comprehensive loss (8,494) (7,716)
Accumulated deficit (1,591,864) (1,542,175)
Total equity 1,117,755 1,157,151
Total liabilities and equity $ 1,314,060 $ 1,381,519